Baller Alert
  • Home
    • News
    • Entertainment
    • The Baller Alert Show
    • Baller Alert Lists
    • Baller Alert Exclusives
    • Let Me Liv
    • Ballerific Music
    • That’s Baller
    • Fashion
    • Metaverse
    • Tech
    • Lifestyle
    • Sports
    • Op-Ed
    • Travel
    • Health
  • EVENTS
  • Videos
  • Shop
  • About
  • Political News
  • en español
No Result
View All Result
  • Home
    • News
    • Entertainment
    • The Baller Alert Show
    • Baller Alert Lists
    • Baller Alert Exclusives
    • Let Me Liv
    • Ballerific Music
    • That’s Baller
    • Fashion
    • Metaverse
    • Tech
    • Lifestyle
    • Sports
    • Op-Ed
    • Travel
    • Health
  • EVENTS
  • Videos
  • Shop
  • About
  • Political News
  • en español
No Result
View All Result
Baller Alert
No Result
View All Result

Supreme Court Rejects Attempt to Restrict Access to Abortion Pill

by Simone
June 13, 2024
Reading Time: 2 mins read
0
Supreme Court Allows Trump Administration to Keep Fired Federal Workers Off Payroll—For Now

istock

Share on FacebookShare on Twitter

In a unanimous decision, the U.S. Supreme Court ruled on Thursday that a group of doctors lacked the legal standing to challenge the Food and Drug Administration’s (FDA) regulation of the abortion pill mifepristone, thus ensuring continued access to the medication nationwide. Justice Brett Kavanaugh authored the opinion, marking another significant moment for abortion rights following the conservative majority’s 2022 decision to overturn Roe v. Wade.

Justice Kavanaugh wrote, “Plaintiffs are pro-life, oppose elective abortion, and have sincere legal, moral, ideological, and policy objections to mifepristone being prescribed and used by others. Because plaintiffs do not prescribe or use mifepristone, plaintiffs are unregulated parties who seek to challenge FDA’s regulation of others.” The court determined that the plaintiffs’ complex theories failed to prove any direct injury from the FDA’s actions, thus lacking the necessary standing under Article III.

Mifepristone, part of a two-drug regimen for medication abortions, remains the most common method of abortion in the U.S. With this ruling, mifepristone will continue to be available under existing conditions, which include mail delivery and no in-person dispensation requirement.

The lead plaintiff, the Alliance for Hippocratic Medicine, represented anti-abortion rights doctors who argued that the FDA’s regulations were flawed. The Biden administration defended the FDA, emphasizing the agency’s scientific backing and decades of safe use. The court’s decision focused primarily on the issue of standing, with Kavanaugh concluding that the plaintiffs “failed to demonstrate that FDA’s relaxed regulatory requirements likely would cause them to suffer an injury in fact.”

Kavanaugh further noted that federal courts were not the appropriate venue for the plaintiffs’ grievances. Instead, concerns should be directed to the President, the FDA, or Congress.

Drug manufacturer Danco, which supported mifepristone’s defense, praised the ruling. A spokeswoman for Danco, Abigail Long, stated, “The court maintained the stability of the FDA drug approval process, which is based on the agency’s expertise and on which patients, healthcare providers, and the U.S. pharmaceutical industry rely.”

However, abortion opponents expressed their disappointment. Susan B. Anthony Pro-Life America policy director Katie Daniel remarked, “It is a sad day for all who value women’s health and unborn children’s lives, but the fight to stop dangerous mail-order abortion drugs is not over.”

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on X (Opens in new window) X
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to email a link to a friend (Opens in new window) Email
  • Click to share on Pinterest (Opens in new window) Pinterest

Like this:

Like Loading...

Discover more from Baller Alert

Subscribe to get the latest posts sent to your email.

Related Posts

U.S. Treasury Says Goodbye to the Penny, Sparking Change in Cash Transactions
News

U.S. Treasury Says Goodbye to the Penny, Sparking Change in Cash Transactions

May 22, 2025

The penny’s days are officially numbered. The U.S. Treasury confirmed it’s phasing out the production of one-cent coins and will...

Remy Ma and Papoose
News

Remy Ma Explodes on IG Live: “You Just Filed Today—Stop Playing with Me!” [Video]

May 22, 2025

Remy Ma isn’t holding back anymore. Just hours after Papoose shared an email showing he filed for divorce, the Bronx...

Papoose Breaks Silence with Receipts After Remy Ma’s IG Live: “You Just Called Me Yesterday Trying to Get Back!”
News

Papoose Breaks Silence with Receipts After Remy Ma’s IG Live: “You Just Called Me Yesterday Trying to Get Back!”

May 22, 2025

It didn’t take long for Papoose to respond after Remy Ma’s Instagram Live, and this time, he came with proof. The...

China Pushes Back: TikTok Sale Stalls After U.S. Tariffs Spark Tension
News

TikTok Shop Employees Told to Work From Home Ahead of “Difficult Decisions” and Potential Layoffs

May 22, 2025

TikTok’s e-commerce division may be facing significant changes. On Tuesday, employees at TikTok Shop U.S. were informed via internal memo...

Next Post
HBCU Alum Willie Mack Vies for the Lead at the 124th US Open, His First Major

HBCU Alum Willie Mack III Vies for the Lead at the 124th US Open, His First Major

Leave a ReplyCancel reply

Baller News

Subscribe To Our Newsletter

* indicates required

Follow Us

Subscribe to Blog

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

© Copyright 2024, Baller Alert Inc. All Rights Reserved

No Result
View All Result
  • Home
    • News
    • Entertainment
    • The Baller Alert Show
    • Baller Alert Lists
    • Baller Alert Exclusives
    • Let Me Liv
    • Ballerific Music
    • That’s Baller
    • Fashion
    • Metaverse
    • Tech
    • Lifestyle
    • Sports
    • Op-Ed
    • Travel
    • Health
  • EVENTS
  • Videos
  • Shop
  • About
  • Political News
  • en español
%d